Documenten
Subscription Forms
Aescap Life Sciences
Subscription Form
Additional Subscription Form
Aescap Genetics
Subscription Form
Additional Subscription Form
FATCA Forms
Self-certification form individuals (FATCA)
Self-certification form entities (FATCA)
Aescap Life Sciences
Prospectus Aescap Life Sciences
Explanation updated Prospectus Aescap Life Sciences
Statement regarding Sustainable Finance Disclosure Regulation
2022 Principal Adverse Impact (PAI) Report Aescap Life Sciences
Aescap Genetics
Prospectus Aescap Genetics
Explanation updated Prospectus Aescap Genetics
Statement regarding Sustainable Finance Disclosure Regulation
2022 Principal Adverse Impact (PAI) Report Aescap Genetics
Aescap Life Sciences – Key Information Document
KID – Investors Unit Class
KID – Investors €10M+ Unit Class
KID – Investors €20M+ Unit Class
KID – Investors €30M+ Unit Class
KID – Investors UK Unit Class
KID – Investors <500k Unit Class
KID – Investors Manager Unit Class
KID – Unit Class Aescap Life Sciences – Investors Allfunds
Aescap Genetics – Key Information Document
KID – Investors Unit Class
KID – Investors €10M+ Unit Class
KID – Investors €20M+ Unit Class
KID – Investors €30M+ Unit Class
KID – Investors Manager Unit Class
Fund Manager
Semi-Annual Report 2023
Annual Report 2022
Semi-Annual Report 2022
Annual Report 2021
Semi-Annual Report 2021
Annual Report 2020
Semi-Annual Report 2020
Annual Report 2019
Semi-Annual Report 2019
Annual Report 2018
Semi-Annual Report 2018
Annual Report 2017
Semi-Annual Report 2017
Annual Report 2016
Semi-Annual Report 2016
Annual Report 2015
Semi-Annual Report 2015
Annual Report 2014
Annual Report 2013
Annual Report 2012
Financial Reports Aescap Life Sciences
Semi-Annual Report 2024
Annual Report 2023
Semi-Annual Report 2023
Annual Report 2022
Semi-Annual Report 2022
Annual Report 2021
Semi-Annual Report 2021
Annual Report 2020
Semi-Annual Report 2020
Annual Report 2019
Semi-Annual Report 2019
Annual Report 2018
Annual Report 2017/2016 (Extended Bookyear)
Financial Reports Aescap Genetics
